Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and...
markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSXV:SBM - Post Discussion
Sirona Biochem Corp
> SBM mgmt, get on with it
New Post
View:
Discussion
List
(1858)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jun 01, 2023 4:24pm
SBM mgmt, get on with it
https://www.newswire.ca/news-releases/bioformula-select-s-stop-guessing-skincare-line-expands-to-canada-832529484.html
(125)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jun 01, 2023 9:22pm
The shelves are full with products that don't work well and yet still find oddly remarkable growth channels. I have tried many and the women around me say the exact same thing. We should all be looking forward to market introduction of the TFC 1067 dyschromia treatment, and we finally get our payday with AbbVie. The question I have is how global it gets and what share of product sales can
...more
(1183)
•••
navajojoe
X
View Profile
View Bullboard History
Comment by
navajojoe
on Jun 02, 2023 8:29am
Considering we gave Abbvie a GLOBAL and EXCLUSIVE licence for TFC-1067, and not JUST for TFC-1067 but some related products that come from certain patents, we darn well better get something significant in the form of CASH. If this turns out to be another R&F joke, the next annual meeting won't be pleasant for management. And we are coming up on the 1-year anniversary of the Abbvie
...more
(101)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Jun 02, 2023 9:06am
Hard to believe it has been a year since they signed the Abbie deal. And what updates have been provided since the deal was signed? Zero zip zilch. Typical SBM protocol - talk talk talk then when actual details are needed they go radio silent and will start pointing to the next shiny object with hopes shareholders will be distracted by that. You would think a milestone of some
...more
(1183)
•••
navajojoe
X
View Profile
View Bullboard History
Comment by
navajojoe
on Jun 02, 2023 12:17pm
Every time Howie signs another one of these go-nowhere deals, it makes one wonder just what the heck he is doing, other than cashing a paycheck.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This profitable gold stock is on its way up
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project